Roche Holding | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
AbbVie USD 9.34B 1.36B 2025-03
Alcon AG USD 1.38B 2M 2025-03
Almirall EUR 191.9M 185.49M 2025-03
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.98B 637M 2025-06
Bayer EUR 8.11B 2.11B 2025-03
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Eli Lilly USD 10.5B 624.7M 2025-03
Fresenius EUR 1.41B 4M 2025-03
Fresenius Medical Care EUR 1.22B 31M 2025-06
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 673M 5.43B 2025-03
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 692M 64M 2024-12
Lonza CHF 1.04B 72M 2024-12
Merck EUR 3.03B 118M 2025-06
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Orion EUR 248.3M 46.5M 2025-06
Pfizer USD 11.12B 987M 2025-03
Philips EUR 2.01B 162M 2025-06
Recordati EUR 423.85M 34.92M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12


Roche Holding Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Aug 2025.